Clinical Trial Update: Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries

View source ↗

Summary

This clinical trial update describes a study sponsored by AbbVie to assess the prevalence of Folate Receptor Alpha in adult women with ovarian cancer across Int…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: AbbVie | Conditions: Ovarian Cancer | Status: NOT_YET_RECRUITING